Free shipping on all orders over $ 500

GSK3145095

Cat. No. M11184

All AbMole products are for research use only, cannot be used for human consumption.

GSK3145095 Structure
Size Price Availability Quantity
5mg USD 350  USD350 In stock
10mg USD 600  USD600 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

GSK3145095 is a potent inhibitor of the oral activity RIP1 kinase with an IC50 of 6.3 nM with potential antitumor and immunomodulatory activity.

Chemical Information
Molecular Weight 397.38
Formula C20H17F2N5O2
CAS Number 1622849-43-7
Form Solid
Solubility (25°C) DMSO ≥ 60 mg/mL
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
References

[1] Philip A Harris, et al. ACS Med Chem Lett. Identification of a RIP1 Kinase Inhibitor Clinical Candidate (GSK3145095) for the Treatment of Pancreatic Cancer

Related RIPK Products
RIP1/RIP3/MLKL activator 1

RIP1/RIP3/MLKL activator 1 is a potent, blood-brain barrier permeable anti-glioma agent. RIP1/RIP3/MLKL activator 1 induces necroptosis through RIP1/RIP3/MLKL pathway.

Oditrasertib 

Oditrasertib is a receptor-interacting protein kinase 1 (RIPK1) inhibitor with an IC50 value lower than 100 nM.

OD36 hydrochloride 

OD36hydrochloride is a RIPK2 inhibitor with an IC50 of 5.3 nM.

RIPK1-IN-12

RIPK1-IN-12 is a potent RIPK1 inhibitor.

DNL747

DNL747 is an ASK1 and RIPK1 inhibitor for studies related to Alzheimer's disease, amyotrophic lateral sclerosis, and multiple sclerosis.

  Catalog
Abmole Inhibitor Catalog




Keywords: GSK3145095 supplier, RIPK, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.